Shaping the future
of animal health
Products

CLINTABS® (clindamycin hydrochloride) Tablets

The only clindamycin antibiotic available in an easy-to-swallow tablet form.

Clindamycin hydrochloride tablets are indicated for the treatment of susceptible dental and skin infections, deep wounds and abscesses, and osteomyelitis in dogs. Refer to the product insert for more information on specific pathogen and treatment indications.

  • Proven effective oral antibiotic treatment in dogs for dental infections caused by Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum, and Clostridium perfringens.
  • Also treats skin infections (wounds and abscesses) due to coagulase positive staphylococci (Staphylococcus aureus or Staphylococcus intermedius). It is also indicated to treat deep wounds and abscesses due to Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens. In addition, it treats osteomyelitis due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.
  • Exclusive easy-to-swallow tablet form makes administration and compliance easy for dog owners.
  • Administer every 12 hours for up to 28 days as needed. For acute infections, discontinue use after 3 to 4 days if no response is seen.

Contraindicated in animals with a history of hypersensitivity to clindamycin or lincomycin. Do not use in rabbits, hamsters, guinea pigs, horses, chinchillas or ruminating animals. Keep out of reach of children. Not for human use. Use with caution in patients with very severe kidney or liver disease and in animals receiving neuromuscular blocking agents such as succinylcholine. Safety in pregnant females or breeding males has not been established. Treatment of acute infections should not be continued for more than three or four days if no response to therapy is seen. Monitor bloodwork in animals on either high dose or prolonged therapy. Side effects occasionally observed include vomiting and diarrhea. For complete product information refer to the product insert.

Ordering Information

Available Sizes

Description Product Number
25 mg – 400 count 902540
75 mg – 200 count 907520
150 mg – 100 count 915010
CLINTABS<sup>®</sup> (clindamycin hydrochloride) Tablets

Click image to enlarge

CLINTABS<sup>®</sup> (clindamycin hydrochloride) Tablets
Additional Product Information
Download MSDS
Download Product Information Insert
FAQs

Can CLINTABS® (clindamycin hydrochloride) Tablets be given to cats?

All studies conducted as a part of the FDA approval process for CLINTABS Tablets were performed on dogs only.

Contraindicated in animals with a history of hypersensitivity to clindamycin or lincomycin. Do not use in rabbits, hamsters, guinea pigs, horses, chinchillas or ruminating animals. Keep out of reach of children. Not for human use. Use with caution in patients with very severe kidney or liver disease and in animals receiving neuromuscular blocking agents such as succinylcholine. Safety in pregnant females or breeding males has not been established. Treatment of acute infections should not be continued for more than three or four days if no response to therapy is seen. Monitor bloodwork in animals on either high dose or prolonged therapy. Side effects occasionally observed include vomiting and diarrhea. For complete product information refer to the product insert.

People who viewed this product also viewed